Integra Lifesciences price to free cash flow IART

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 35.9×
10-year median: 35.0×
Against its 10-year history: 52nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 14.8× to 377×
Peer median: 18.8×

Integra Lifesciences' price to free cash flow is 35.9× as of Oct 23, 2026.

That is above its ten-year median of 35.0×, close to the middle of its last ten years.

Over that time it ranged from 14.8× in Dec 2016 to 377× in Jul 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 18.8×.

Price to free cash flow over time

median 35×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	35.9×	35.9×	377×
2025	52.1×	42.9×	71.8×
2024	45.3×	22.4×	50.3×
2023	31.0×	15.8×	31.8×
2022	24.3×	16.8×	24.4×
2021	19.3×	18.0×	38.2×
2020	34.2×	19.7×	45.4×
2019	45.0×	35.7×	47.8×
2018	36.7×	36.7×	72.5×
2017	64.2×	16.2×	67.7×
2016	16.7×	14.8×	65.0×
2015	43.9×	32.2×	60.8×
2014	57.4×	50.1×	292×
2013	27.2×	27.2×	29.5×
2012	26.0×	12.1×	27.0×
2011	15.2×	14.3×	24.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.

Company	Price to free cash flow
IARTIntegra Lifesciences	35.9×
IRMDIradimed	43.7×
STAAStaar Surgical	n/m
MOVMovado	9.8×
BVSBioventus	13.3×
CDRECadre	16.4×
EYENational Vision	30.1×
MDXGMimedx	n/m
TCMDTactile Systems Technology	20.0×
LMATLemaitre Vascular	26.2×
INSPInspire Medical Systems	17.6×
Peer median	18.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Integra Lifesciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.